Biotech Values

[DewDiligence]

The analogy with inhaled insulin is well-taken, IMO.

While NKTR and ALKS continue to talk up the prospects for their inhaled-insulin products eventually getting to market, you get quite a different tune when you listen to PFE and LLY, which are NKTR’s and ALKS’ inhaled-insulin partners, respectively.